LakeShore Biopharma Reports Change in Control
Ticker: LSBWF · Form: 6-K · Filed: Jul 15, 2025 · CIK: 1946399
| Field | Detail |
|---|---|
| Company | Lakeshore Biopharma CO., LTD. (LSBWF) |
| Form Type | 6-K |
| Filed Date | Jul 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: change-of-control, corporate-action, foreign-issuer
Related Tickers: LAKESHORE
TL;DR
LakeShore Biopharma (LAKESHORE) just filed a 6-K reporting a change in control. Big implications for the stock.
AI Summary
On July 8, 2025, LakeShore Biopharma Co., Ltd. reported a change in control. The company, formerly known as YS Biopharma Co., Ltd. and YishengBio Co., Ltd., is headquartered in Beijing, PRC.
Why It Matters
A change in control can significantly impact a company's strategic direction, management, and shareholder value.
Risk Assessment
Risk Level: medium — Change in control events can introduce uncertainty regarding future strategy and operations.
Key Players & Entities
- LakeShore Biopharma Co., Ltd. (company) — Registrant
- YS Biopharma Co., Ltd. (company) — Former company name
- YishengBio Co., Ltd (company) — Former company name
- July 8, 2025 (date) — Date of change in control
FAQ
What is the exact nature of the change in control reported by LakeShore Biopharma?
The filing explicitly states that LakeShore Biopharma Co., Ltd. entered into an agreement on July 8, 2025, which resulted in a change in control, but the specific details of this agreement are not provided in the excerpt.
When did LakeShore Biopharma change its name from YS Biopharma Co., Ltd.?
The company changed its name from YS Biopharma Co., Ltd. on March 10, 2023.
What was LakeShore Biopharma's previous name before YS Biopharma Co., Ltd.?
Before being known as YS Biopharma Co., Ltd., the company was named YishengBio Co., Ltd., with the name change occurring on September 12, 2022.
Where is LakeShore Biopharma's principal executive office located?
LakeShore Biopharma's principal executive offices are located at Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park, Daxing District, Beijing, PRC.
Does LakeShore Biopharma file annual reports under Form 20-F or Form 40-F?
LakeShore Biopharma indicates that it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 15, 2025 regarding LakeShore Biopharma Co., Ltd. (LSBWF).